Plasmin: A driver of hemovascular dysfunction

Blood

Volumn 128, Issue 20, 2016, Pages 2375-2376

  Cap, Andrew P ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; HIGH MOLECULAR WEIGHT KININOGEN; PLASMIN;

ENZYME ACTIVITY; FIBRINOLYSIS; HEMORRHAGIC SHOCK; HUMAN; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; REVIEW;

FIBRINOLYSIN; HUMANS;

EID: 85015389162     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-09-735720     Document Type: Review

References (10)

1. Marcos-Contreras OA, Martinez de Lizarrondo S, Bardou I, et al. Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin-and bradykinindependent mechanism. Blood. 2016;128(20):2423-2434.
2. Hurford R, Rezvani S, Kreimei M, et al. Incidence, predictors and clinical characteristics of orolingual angiooedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke. J Neurol Neurosurg Psychiatry. 2015;86(5):520-523.
3. Cagliani R, Forni D, Riva S, et al. Evolutionary analysis of the contact system indicates that kininogen evolved adaptively in mammals and in human populations. Mol Biol Evol. 2013;30(6):1397-1408.
4. Hofman Z, de Maat S, Hack CE, Maas C. Bradykinin: inflammatory product of the coagulation system. Clin Rev Allergy Immunol. 2016;51(2):152-161.
5. Renckens R, Weijer S, de Vos AF, et al. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia. Arterioscler Thromb Vasc Biol. 2004;24(3):483-488.
6. Tracy RP, Rubin DZ, Mann KG, et al. Thrombolytic therapy and proteolysis of factor V. J Am Coll Cardiol. 1997;30(3):716-724.
7. Nogami K, Shima M, Matsumoto T, Nishiya K, Tanaka I, Yoshioka A. Mechanisms of plasmin-catalyzed inactivation of factor VIII: a crucial role for proteolytic cleavage at Arg336 responsible for plasmin-catalyzed factor VIII inactivation. J Biol Chem. 2007;282(8): 5287-5295.
8. Kaplan AP, Ghebrehiwet B. The plasma bradykininforming pathways and its interrelationships with complement. Mol Immunol. 2010;47(13):2161-2169.
9. Kunz M, Nussberger J, Holtmannspötter M, Bitterling H, Plesnila N, Zausinger S. Bradykinin in blood and cerebrospinal fluid after acute cerebral lesions: correlations with cerebral edema and intracranial pressure. J Neurotrauma. 2013;30(19): 1638-1644.
10. Collaborators, C.-t., et al., Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734):23-32.